Parallel Advisors »

First Tracks Biotherapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.1k 55 20.13

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Corcept Therapeutics Stock (CORT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Avantis International Equity Etf Etf (AVDE)
Victoryshares Free Cash Flow Etf Etf (VFLO)
Cvb Finl Corp Stock (CVBF)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Vanguard Large Cap Etf (VV)

View all positions for Parallel Advisors

Top funds holding First Tracks Biotherapeutics

Sanofi
Financial Enhancement
Bank of New York Mellon
Moody Aldrich Partners
Fisher Investments
Tema Etfs
Russell Investments
Victory Capital Management
New York State Common Retirement Fund
China Universal Asset Management
OTR - Nominee Name for The State Teachers Retirement Board of Ohio
GAMMA Investing
Sterling Capital Management
EverSource Wealth Advisors
Rothschild Investment

View all funds holding First Tracks Biotherapeutics